GLP-1 Agonists: Wonder Drugs of the 21st Century?
Setup
The first drug in a class known as GLP-1 agonists was approved in 2005 to treat diabetes. GLP-1 drugs subsequently proved their mettle to treat obesity and prevent major cardiovascular events and will likely soon be available to treat sleep apnea as well. Looking ahead, their action on the brain is prompting research to gauge their value in curbing drug, alcohol, and nicotine cravings. But these seeming miracle drugs are costly, not always covered by insurance, and generally need to be taken forever. How do they work, what else might they do, and how do we ensure they are accessible to those who need them most?
Explore More
Health
Few people are more deeply steeped in science than Francis Collins, former director of the National Institutes of Health and the groundbreaking Human Genome Project, and forme...
Climate change is a threat multiplier with a disproportionate impact on vulnerable populations. Girls and women, who are denied equitable access to education and economic oppo...
Featuring inspiring conversations, the closing session is not to be missed. First, U.S. Surgeon General Vivek Murthy and Jennifer Ashton of ABC News explore the loneliness epi...
The idea of gathering DNA samples into a vast database in order to identify disease risks and breakthrough therapies was once a distant dream. Not long ago, immunotherapy seem...
The 3M’s—Medicare, Medicaid and the Children’s Health Insurance Program, and the Affordable Care Act Marketplaces—cover more than 160 million people across the country, nearly...
Scientific investigation is laser focused on psychedelics to treat post-traumatic stress disorder (PTSD), ease end-of-life anxiety, and address mental health challenges, inclu...
Human beings sometimes forget they are animals themselves. The biological and emotional patterns of other mammals—seen in cancer among golden retrievers, high blood pressure i...
History was made this year when the first FDA-approved CRISPR-based gene editing therapy became available to patients, designed to cure sickle cell anemia. That represents gr...
Although most Americans (83%) still trust their doctors to tell them the truth about health issues, fewer than half have faith in healthcare CEOs, government leaders, or journ...
The science-based Centers for Disease Control and Prevention (CDC) is the linchpin of the nation’s public health system. With its state-of-the art laboratories, world-class da...
AI is transforming health, with implications for early disease detection, diagnostic accuracy, medical decision making, precision surgery, and personalized treatments. By spee...
Lessening the anguish of firearms injury demands that we reach across ideological divides. No one—not gun owners or health systems, not parents or politicians of any party—con...
Join us to kickoff Aspen Ideas: Health 2024 with welcome remarks from Aspen Institute leaders, 10 Big Ideas from Aspen Ideas: Health speakers, and a special performance from t...
What health issues will play a role at the ballot box this election season? And will they influence voter turnout? As 2024 campaigns heat up, pollsters want to know what most...
In a live podcast recording, health policy journalists talk about hot-button health issues and what they mean for the upcoming election. From the Affordable Care Act, Medicaid...
Meet Maymunah Yusuf Kadiri (aka Dr. May), a 2024 Aspen Ideas: Health Fellow and the Psychiatrist-In-Chief at Pinnacle Medical Services, Nigeria’s leading mental health center....
Whether you love setting New Year’s resolutions or ignore them entirely, there’s still a certain mix of nostalgia and excitement over the ending of one year and the possibilit...
Meet Georgina Dukes-Harris, a 2024 Aspen Ideas: Health Fellow and the Founder of Swishvo. Having experienced critical gaps in maternal healthcare firsthand, she's on a mission...
People and families suffering from Alzheimer’s and dementia often feel desperate for a cure and will try anything. Unfortunately, no cure exists and not a single treatment has...
Meet Ar’Sheill Monsanto, a 2024 Aspen Ideas: Health Fellow and the Vice President of Strategy and Partnerships for Link Health. Learn how she's bringing healthcare, higher edu...
